Bokf, Na Becton Dickinson & CO Transaction History

Bokf, Na

$5.9 Billion
Q4 2024

A detailed history of Bokf, Na transactions in Becton Dickinson & CO stock. As of the latest transaction made, Bokf, Na holds 12,296 shares of BDX stock, worth $2.82 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

12,296

Previous 5,951 106.62%

Holding current value

$2.82 Million

Previous $1.43 Million 94.49%

% of portfolio

0.05%

Previous 0.03%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$220.02 - $243.75 $1.4 Million - $1.55 Million	6,345 Added 106.62%	12,296 $2.79 Million
Q3 2024 Nov 14, 2024	SELL	$221.47 - $242.41 $99,218 - $108,599	-448 Reduced 7.0%	5,951 $1.43 Million
Q2 2024 Aug 07, 2024	SELL	$225.07 - $246.17 $502,581 - $549,697	-2,233 Reduced 25.87%	6,399 $1.5 Million
Q1 2024 May 15, 2024	BUY	$233.45 - $247.73 $68,400 - $72,584	293 Added 3.51%	8,632 $2.14 Million
Q4 2023 Feb 14, 2024	SELL	$232.24 - $267.23 $147,704 - $169,958	-636 Reduced 7.09%	8,339 $2.03 Million
Q3 2023 Nov 14, 2023	SELL	$254.9 - $283.59 $846,777 - $942,085	-3,322 Reduced 27.01%	8,975 $2.32 Million
Q2 2023 Aug 21, 2023	BUY	$238.39 - $265.32 $46,486 - $51,737	195 Added 1.61%	12,297 $3.25 Million
Q1 2023 May 11, 2023	SELL	$229.71 - $259.35 $2.96 Million - $3.35 Million	-12,903 Reduced 51.6%	12,102 $3 Million
Q4 2022 Feb 13, 2023	SELL	$218.29 - $256.91 $947,815 - $1.12 Million	-4,342 Reduced 14.8%	25,005 $6.36 Million
Q3 2022 Nov 14, 2022	SELL	$51.03 - $264.23 $32,914 - $170,428	-645 Reduced 2.15%	29,347 $6.54 Million
Q2 2022 Aug 11, 2022	SELL	$234.74 - $275.42 $1.21 Million - $1.42 Million	-5,151 Reduced 14.66%	29,992 $7.39 Million
Q1 2022 May 13, 2022	BUY	$243.64 - $270.48 $502,142 - $557,459	2,061 Added 6.23%	35,143 $9.35 Million
Q4 2021 Mar 11, 2022	SELL	$230.08 - $250.94 $123,092 - $134,252	-535 Reduced 1.59%	33,082 $8.32 Million
Q3 2021 Nov 10, 2021	SELL	$232.72 - $256.47 $2.33 Million - $2.56 Million	-9,991 Reduced 22.91%	33,617 $8.26 Million
Q1 2021 Apr 21, 2021	BUY	$232.09 - $256.88 $7,891 - $8,733	34 Added 0.08%	43,608 $10.6 Million
Q4 2020 Feb 12, 2021	SELL	$221.92 - $245.94 $44,162 - $48,942	-199 Reduced 0.45%	43,574 $10.9 Million
Q3 2020 Oct 30, 2020	SELL	$215.77 - $276.76 $28,050 - $35,978	-130 Reduced 0.3%	43,773 $10.2 Million
Q2 2020 Aug 12, 2020	SELL	$219.9 - $263.41 $697,302 - $835,273	-3,171 Reduced 6.74%	43,903 $10.5 Million
Q1 2020 May 13, 2020	SELL	$195.69 - $279.01 $182,774 - $260,595	-934 Reduced 1.95%	47,074 $10.8 Million
Q4 2019 Feb 12, 2020	SELL	$236.45 - $266.82 $575,755 - $649,706	-2,435 Reduced 4.83%	48,008 $13.1 Million
Q3 2019 Nov 13, 2019	BUY	$230.58 - $256.08 $250,409 - $278,102	1,086 Added 2.2%	50,443 $12.8 Million
Q2 2019 Aug 14, 2019	BUY	$217.4 - $246.08 $440,017 - $498,065	2,024 Added 4.28%	49,357 $12.4 Million
Q1 2019 May 15, 2019	BUY	$206.05 - $248.17 $1.44 Million - $1.73 Million	6,968 Added 17.26%	47,333 $11.8 Million
Q4 2018 Feb 13, 2019	BUY	$204.73 - $257.93 $2.05 Million - $2.58 Million	10,019 Added 33.02%	40,365 $9.1 Million
Q3 2018 Nov 13, 2018	SELL	$233.07 - $256.0 $312,080 - $342,784	-1,339 Reduced 4.23%	30,346 $7.92 Million
Q2 2018 Aug 13, 2018	BUY	$208.1 - $233.85 $117,992 - $132,592	567 Added 1.82%	31,685 $7.59 Million
Q1 2018 May 14, 2018	BUY	$205.46 - $240.27 $742,943 - $868,816	3,616 Added 13.15%	31,118 $6.74 Million
Q4 2017 Feb 14, 2018	BUY	$189.0 - $222.64 $137,214 - $161,636	726 Added 2.71%	27,502 $5.89 Million
Q3 2017 Nov 14, 2017	BUY	$186.89 - $198.9 $193,804 - $206,259	1,037 Added 4.03%	26,776 $5.25 Million
Q2 2017 Aug 14, 2017	BUY	N/A	25,739	25,739 $5.02 Million

Others Institutions Holding BDX

# of Institutions

1,815

Shares Held

259M

Call Options Held

1.2M

Put Options Held

1.09M

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.3B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.

Account